CRISPR Technology Market: Off-Target Activity and the Presence of Alternative Technologies

The research study involves four major activities in estimating the current market size for CRISPR technology. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134401204

Major Market Growth Drivers:

The rise in the availability of government and private funding and the adoption of CRISPR technology are the key factors driving the growth of CRISPR Services Market.

Revenue Growth Analysis:

[163Pages Report] The CRISPR technology market is expected to grow from USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25% during the forecast period.

Browse and in-depth TOC on "CRISPR Technology Market "

132 – Tables
24 – Figures
163 – Pages

By product and service, the CRISPR services segment is expected to be the fastest-growing in the CRISPR technology market during the forecast period.

The services segment forms the fastest-growing segment in the market, by product and service. Based on service, the CRISPR services market is segmented into gRNA design and vector construction, cell line engineering, screening services, and other CRISPR services (mediated transcriptome editing and epigenome editing services). The cell line engineering services segment is expected to grow at the highest rate.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=134401204

By application, the biomedical applications segment accounted for the largest share during the forecast period.

The major biomedical applications of CRISPR include gene therapy, drug discovery, and diagnostics. Across the globe, various gene therapy clinical trials are currently underway. These factors are expected to drive the adoption of CRISPR technology in this segment. In drug discovery applications, CRISPR is used to develop more physiologically relevant models (cell lines and animal models) that correlate better to the clinical setting and thereby reduce drug candidate failure in the initial steps. The ability to modify endogenous genes can help to study the effect of drugs on targets along with endogenous proteins, rather than having to rely on overexpression.

North America is expected to account for the largest CRISPR Products Market share during the forecast period.

North America is estimated to account for the largest share of the CRISPR Products Market in 2018. This is majorly attributed to the rising government and private funding, presence of major pharma and gene therapy companies, and the adoption of CRISPR in several applications. Furthermore, crops that are treated with CRISPR-based gene editing are not considered as GMOs in US; this has attracted a number of agricultural companies to focus on the commercialization of CRISPR-edited crops.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Key CRISPR Services Market Players:

The key players operating in the global CRISPR Services Market are Cellecta, Inc. (US), Thermo Fisher (US), GeneCopoeia, Inc. (US), Applied StemCell (US), Synthego Corporation (US), OriGene Technologies (US), Horizon Discovery (UK), Merck (Germany), and GenScript (US).